The Latest Cardiac and Vascular News
Santa Monica, CA, Feb. 26, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that the Company appointed a Senior R&D Engineer and is working on further senior […]
MOUNTAIN VIEW, Calif., Feb. 26, 2019 /PRNewswire/ — AliveCor, the leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced Jacqueline Shreibati, MD, MS, FACC, as Chief Medical Officer of the company. In her new role, Dr. Shreibati will lead AliveCor’s medical roadmap, developing innovative products that employ digital intelligence to improve heart care […]
MARLBOROUGH, Mass., Feb. 25, 2019 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) completed a public offering of $4.3 billion aggregate principal amount of its senior notes. The public offering consists of $850 million of 3.450% notes due 2024, $850 million of 3.750% notes due 2026, $850 million of 4.000% notes due 2029, $750 millionof 4.550% notes due 2039 and $1.0 billion of 4.700% notes due […]
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the fourth quarter and full year 2018. Recent Highlights Sold five Senhance Systems […]
VANCOUVER, Feb. 26, 2019 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN / TSX: NVCN) announced today the pricing of its previously announced underwritten public offering (the “Offering”) of 11,111,111 common shares of the Company (the “Common Shares”) at a price to the public of US$0.45 per Common Share, for aggregate gross proceeds to the […]
KFAR-SABA, Israel & ALISO VIEJO, Calif.–(BUSINESS WIRE)–CathWorks announced that Ramin Mousavi has joined CathWorks as Vice President of Global Marketing & Strategy. Mr. Mousavi, an experienced cardiovascular marketer, will take responsibility for the CathWorks FFRangio™ System U.S. clinical and commercial launch and direct future expansion into other global markets. Mr. Mousavi […]
SAN DIEGO, Feb. 24, 2019 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”) said today that on 25 February 2019 (AEDT), the Australian Securities Exchange issued a market announcement indicating that the securities of the Company will remain suspended from quotation at the Company’s request until […]
BEDMINSTER, N.J., Feb. 25, 2019 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company, today announced that it has appointed a prominent cardiovascular medical and clinical development expert, James (“Terry”) J. Ferguson, M.D., FACC, FAHA, as its Chief Medical Officer. Dr. Ferguson is a well-recognized, industry leading […]
IRVINE, Calif.–(BUSINESS WIRE)–Nihon Kohden, a U.S. market leader in precision medical products and services, today announced the appointment of Yasuhiro Yoshitake as its new president and CEO. Yoshitake is taking over the helm of the organization from Dr. Wilson P. Constantine, who led the organization from April 2015 to February […]
PLANO, Texas, Feb. 21, 2019 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the fourth quarter and fiscal year ended December 28, 2018. Fourth Quarter 2018 Highlights GAAP Sales from continuing operations increased 0.3% and Non-GAAP Sales from continuing operations increased […]
